Far East Bio-Tec Co., Ltd. (6886) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Far East Bio-Tec Co., Ltd. (6886:TWSE), powered by AI.

Current Price
$47.90
Sector
Consumer Defensive
What is the Far East Bio-Tec Co., Ltd. stock price forecast?

Far East Bio-Tec Co., Ltd. is currently trading at $47.90. View real-time AI analysis on Alpha Lenz.

What is Far East Bio-Tec Co., Ltd. insider trading activity?

View the latest insider trading data for Far East Bio-Tec Co., Ltd. on Alpha Lenz.

What is Far East Bio-Tec Co., Ltd.'s P/E ratio?

View Far East Bio-Tec Co., Ltd.'s valuation metrics on Alpha Lenz.

Far East Bio-Tec Co., Ltd.

TWSE · 6886
NT$47.90+1.95(+4.24%)
Ask about Far East Bio-Tec Co., Ltd.'s future dividend policy...
Alpha Chat Insight

Far East Bio-Tec Co., Ltd.'s ROE is 10.9%. Explore profitability and growth together.

Ask for details

Company Overview

Far East Bio-Tec Co., Ltd. is a biotechnology and health food company specializing in the manufacturing and sale of high-quality microalgae-based products, including organic chlorella, organic spirulina, and a broad range of nutritional and dietary supplements. The company has pioneered the use of microalgae in various applications, offering nutraceuticals, immune boosters, antiviral sprays, and pet supplements, and recently expanded into advanced formulations such as nattokinase and spore-forming probiotics using proprietary fermentation technologies. Far East Bio-Tec is recognized for its commitment to product safety and efficacy, with ISO 22000 and HACCP certifications, and over four decades of experience in the sector. It stands out in research and development, notably becoming the first company in Taiwan to secure an INCI designation for plant-derived microalgae exosomes, enabling its entry into the international skincare market with proprietary biotechnology ingredients. By integrating advanced biotechnology with food and wellness products, Far East Bio-Tec Co., Ltd. plays a significant role in the consumer staples sector, bridging the gap between traditional health foods and innovative biopharmaceutical applications in Asia and beyond.

SectorConsumer Defensive
IndustryPackaged Foods
0

Company Statistics

FY 2025

Profile

N/AMarket Cap
NT$401.70MRevenue
0.00Shares Out
0Employees

Margins

50.50%Gross
24.61%EBITDA
17.08%Operating
18.84%Pre-Tax
14.93%Net

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

1.89%Rev 3Yr
6.54%Rev 5Yr
-14.41%Op Inc 3Yr
15.06%Op Inc 5Yr
-12.86%Net Inc 3Yr
8.57%Net Inc 5Yr

Returns

8.93%ROA
10.89%ROE
11.44%ROIC

Financial Health

NT$271.65MCash & Cash Equivalents
NT$-157.55MNet Debt
19.41%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Far East Bio-Tec Co., Ltd. (ticker: 6886) is a company listed on TWSE in the Consumer Defensive sector (Packaged Foods).

The current price is 47.9 with a P/E ratio of -x and P/B of -x.

ROE is 10.89% and operating margin is 17.08%. Annual revenue is $402M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Far East Bio-Tec Co., Ltd. (6886) Stock Forecast 2026 $47.90 — Price, Financials & Analyst Targets | Alpha Lenz